男性壓力性尿失禁市場規模、佔有率和成長分析：按治療類型、疾病嚴重程度、治療環境、最終用戶、患者年齡層、分銷管道和地區分類－2026-2033年產業預測

2024 年全球男性壓力性尿失禁市值為 6.428 億美元，預計到 2033 年將從 2025 年的 6.8715 億美元成長到 11.7186 億美元，預測期（2026-2033 年）的複合年成長率為 6.9%。

全球男性壓力性尿失禁 (SUI) 市場專注於創新產品和服務，旨在控制因增加腹壓的體力活動引起的尿液滲漏。這對於改善男性生活品質 (QOL) 至關重要，尤其對於那些患有前列腺切除術後併發症、神經系統疾病或骨盆底肌無力等問題的男性而言。近年來，男性專用尿墊和尿道填充物等技術的進步，以及人們對 SUI 的日益關注和男性人口老化，正在推動市場動態。微創治療（例如男性用吊帶和人工尿道括約肌）的引入尤其值得關注。這些治療有望帶來有效且長期的療效，同時降低併發症風險，並在關鍵地區創造有利的保險報銷環境。因此，醫療設備製造商正加大投資，以滿足快速成長的根治性攝護腺切除術患者群體的需求。

全球男性壓力性尿失禁市場促進因素

公眾意識提升活動和醫療專業人員資訊的普及顯著提高了人們對男性壓力性尿失禁的認知。這種認知的提高鼓勵男性及早發現症狀並尋求醫療幫助，從而有效減少了延誤診斷的情況。因此，符合治療條件的患者群體擴大，對多樣化治療方案的需求增加，市場擴張也隨之而來。患者就診範圍從私人診所擴展到公立醫院，促使製造商加快產品創新並加強分銷管道。因此，這些動態因素進一步推動了全球男性壓力性尿失禁市場的成長動能。

全球男性壓力性尿失禁市場限制因素

男性壓力性尿失禁全球市場面臨的主要障礙之一是先進療法的高昂費用。這源於複雜技術和高品質材料的需求。由於費用高昂，醫療專業人員往往不願意推薦這些療法，而更傾向於選擇價格較低廉的傳統療法，尤其是在保險覆蓋範圍有限或自付費用較高的情況下。這種經濟障礙限制了創新療法的普及，尤其是在新興市場和預算緊張的公立醫院，儘管這些療法具有改善患者長期生活品質的潛力，但卻阻礙了整體市場的成長。

全球男性壓力性尿失禁市場趨勢

由於創新吸收技術的出現，全球男性壓力性尿失禁市場正經歷重大變革。新一代超薄吸收芯設計，在提升液體吸收效率的同時，帶來隱密舒適的穿著體驗，進而增強使用者的自信心。製造商正利用先進的聚合物科學和紡織工程技術，開發出符合男性解剖結構的產品，最大限度地減少不適感和異味。這種向更智慧材料的轉變不僅提高了產品標準，也有助於打造高階品牌形象。此外，與泌尿系統專家的合作，使得產品能夠根據生活方式需求進行客製化設計，最終促進長期持續使用，並提升患者滿意度。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球男性壓力性尿失禁市場規模：依治療類型分類

• 男性用吊帶系統
• 人工尿道括約肌
• 藥物治療
• 其他

男性壓力性尿失禁的全球市場規模：依疾病嚴重程度分類

• 輕度尿失禁
• 中度尿失禁
• 嚴重尿失禁

男性壓力性尿失禁的全球市場規模：依治療環境分類

• 手術治療
• 非手術治療

男性壓力性尿失禁的全球市場規模：依最終用戶分類。

• 醫院
• 泌尿系統診所
• 門診手術中心
• 其他

全球男性壓力性尿失禁市場規模：依患者年齡層分類

• 成年患者
• 老年患者

全球男性壓力性尿失禁市場規模：按分銷管道分類

• 醫院藥房
• 零售藥房
• 其他

全球男性壓力性尿失禁市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Boston Scientific Corporation
• Coloplast A/S
• Zephyr Surgical Implants
• Promedon Group
• Rigicon, Inc.
• Uromedica, Inc.
• Teleflex Incorporated
• Becton, Dickinson and Company
• Johnson & Johnson MedTech
• Medtronic plc
• Cook Medical LLC
• Laborie Medical Technologies Corp.
• SRS Medical Systems, Inc.
• UroMems SAS
• Pfizer Inc.
• AbbVie Inc.
• Astellas Pharma Inc.
• Recordati SpA
• Ferring Pharmaceuticals A/S
• Veru Inc.

結論與建議

Global Male Stress Urinary Incontinence Market size was valued at USD 642.8 Million in 2024 and is poised to grow from USD 687.15 Million in 2025 to USD 1171.86 Million by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).

The global male stress urinary incontinence (SUI) market focuses on innovative products and services designed to manage urine leakage triggered by physical activities that increase abdominal pressure. This is vital for enhancing the quality of life for men experiencing issues such as post-prostate surgery complications, neurological disorders, or weakened pelvic muscles. Recent advancements, including male-specific continence pads and urethral bulking agents, coupled with a growing awareness of SUI and an aging male population, are propelling market dynamics. The introduction of minimally invasive solutions like male slings and artificial urinary sphincters is particularly noteworthy, as they promise effective, long-lasting results with reduced complications, fostering favorable reimbursement landscapes in key regions and thereby encouraging investment from medical-device firms aiming to serve a burgeoning demographic of prostatectomy patients.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Male Stress Urinary Incontinence market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Male Stress Urinary Incontinence Market Segments Analysis

Global male stress urinary incontinence market is segmented by treatment type, disease severity, treatment setting, end user, patient age group, distribution channel and region. Based on treatment type, the market is segmented into Male Sling Systems, Artificial Urinary Sphincters, Pharmacological Therapy and Others. Based on disease severity, the market is segmented into Mild Incontinence, Moderate Incontinence and Severe Incontinence. Based on treatment setting, the market is segmented into Surgical Treatment and Non-Surgical Treatment. Based on end user, the market is segmented into Hospitals, Urology Clinics, Ambulatory Surgical Centers and Others. Based on patient age group, the market is segmented into Adult Patients and Geriatric Patients. Based on distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Male Stress Urinary Incontinence Market

The rise in public education initiatives and outreach to healthcare professionals has significantly heightened awareness of male stress urinary incontinence. This increased visibility encourages men to recognize symptoms sooner and seek medical assessments, effectively reducing diagnostic delays. Consequently, a larger patient pool becomes eligible for treatment, fueling the demand for diverse therapeutic options and fostering market expansion. The influx of patients extends beyond private clinics to public hospitals, motivating manufacturers to enhance product innovation and strengthen distribution channels. As a result, these dynamic factors contribute to the escalating growth momentum within the Global Male Stress Urinary Incontinence market.

Restraints in the Global Male Stress Urinary Incontinence Market

A significant barrier in the Global Male Stress Urinary Incontinence market is the elevated costs associated with advanced treatment options, which arise from the need for complex engineering and high-quality materials. Healthcare providers might hesitate to recommend these therapies due to their expensive nature, often opting for more affordable conventional alternatives, particularly when reimbursement options are limited or out-of-pocket expenses are high. This financial hurdle restricts access to innovative solutions, particularly in emerging markets and budget-constrained public hospitals, consequently hindering overall market growth, despite the potential long-term quality of life improvements these therapies can offer patients.

Market Trends of the Global Male Stress Urinary Incontinence Market

The Global Male Stress Urinary Incontinence market is experiencing a significant transformation driven by the emergence of innovative absorbent technologies. Next-generation absorbent cores, designed with ultra-thin structures, are enhancing fluid capture efficiency while ensuring discreet wear, which boosts user confidence. Manufacturers are leveraging advanced polymer science and textile engineering to create products that conform to male anatomy, minimizing discomfort and odor. This shift towards smarter materials not only elevates product standards but also fosters premium branding. Additionally, partnerships with urology specialists are paving the way for tailored designs that align with lifestyle requirements, ultimately promoting long-term adherence and enhancing patient satisfaction.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Male Stress Urinary Incontinence Market Size by Treatment Type & CAGR (2026-2033)

• Market Overview
• Male Sling Systems
• Artificial Urinary Sphincters
• Pharmacological Therapy
• Others

Global Male Stress Urinary Incontinence Market Size by Disease Severity & CAGR (2026-2033)

• Market Overview
• Mild Incontinence
• Moderate Incontinence
• Severe Incontinence

Global Male Stress Urinary Incontinence Market Size by Treatment Setting & CAGR (2026-2033)

• Market Overview
• Surgical Treatment
• Non-Surgical Treatment

Global Male Stress Urinary Incontinence Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Urology Clinics
• Ambulatory Surgical Centers
• Others

Global Male Stress Urinary Incontinence Market Size by Patient Age Group & CAGR (2026-2033)

• Market Overview
• Adult Patients
• Geriatric Patients

Global Male Stress Urinary Incontinence Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Others

Global Male Stress Urinary Incontinence Market Size & CAGR (2026-2033)

• North America (Treatment Type, Disease Severity, Treatment Setting, End User, Patient Age Group, Distribution Channel)
  • US
  • Canada
• Europe (Treatment Type, Disease Severity, Treatment Setting, End User, Patient Age Group, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Treatment Type, Disease Severity, Treatment Setting, End User, Patient Age Group, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Treatment Type, Disease Severity, Treatment Setting, End User, Patient Age Group, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Treatment Type, Disease Severity, Treatment Setting, End User, Patient Age Group, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Coloplast A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zephyr Surgical Implants
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promedon Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rigicon, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Uromedica, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson MedTech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laborie Medical Technologies Corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SRS Medical Systems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• UroMems SAS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Astellas Pharma Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Recordati S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferring Pharmaceuticals A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Veru Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations